Neurology Minute
American Academy of Neurology
The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Episodes
Mentioned books
May 29, 2025 • 2min
Clinical Criteria for LATE
Dr. Greg Cooper and Dr. David A. Wolk discuss limbic predominant age-related TDP-43 encephalopathy (LATE), covering its clinical features, diagnostic criteria, and more. Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.14202
May 28, 2025 • 4min
Optic Nerve Imaging - Part 2
In the second installment of this three-part series, Dr. Elizabeth Zollos discusses the use of magnetic resonance imaging (MRI) in multiple sclerosis diagnosis.
May 27, 2025 • 2min
Introduction to the New AAN President, Natalia S. Rost, MD, MPH, FAAN, FAHA
In the first episode of the AAN President's Spotlight series, Dr. Jason Crowell speaks with the new AAN President, Dr. Natalia S. Rost, as she outlines her vision and key priorities for her two-year term. Show references: https://www.aan.com/about-the-aan/presidents-spotlight
May 26, 2025 • 2min
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 2
In part two of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss how to approach the management of patients in clinic when there is concern for a possible false positive on the radioimmunoprecipitation assay for the acetylcholine receptor antibody. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213498
May 23, 2025 • 2min
False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 1
In part one of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss the clinical scenarios where the commonly used assay for myasthenia gravis is most likely to produce false positive results in patients who do not actually have myasthenia gravis. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213498
May 22, 2025 • 2min
Transforming Neurology Education: Evaluating Teaching Incentive Programs
Dr. Roy E. Strowd and Dr. Susannah Cornes discuss a teaching incentive initiative designed to support and reward faculty in academic neurology. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200182
May 21, 2025 • 5min
Optic Nerve Imaging - Part 1
In the first installment of this three-part series, Dr. Elizabeth Zollos explores how optical coherence tomography is advancing our understanding of multiple sclerosis and enhancing diagnostic accuracy.
May 20, 2025 • 2min
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer explore the subcategories of Lewy body disease, focusing on the body-first subtype Show reference: https://www.nature.com/articles/s41593-025-01910-9
May 19, 2025 • 3min
AAN’s President’s Award Recipient for 2025 - Part 2
In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN. Show reference: https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award
May 16, 2025 • 2min
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1
Dr. Jeff Ratliff and Dr. Per Borghammer delve into the intriguing world of Lewy Body Disease. They contrast the body-first and brain-first models, shedding light on how these theories affect symptoms and disease progression. The discussion uncovers vital insights into postmortem tissue research from individuals before diagnosis, revealing the complexities of this condition. Tune in for a fascinating exploration of neurological pathology and its implications for understanding Lewy Body Disease!
